Short Category Summary

Smoking Cessation

Smoking cessation care at eSupport Health supports evidence-based treatment planning with Varenicline (Chantix) and structured follow-up. Clinicians evaluate safety factors and provide a quit strategy focused on reducing cravings, managing triggers, and preventing relapse through privacy-first telemedicine standards.
Happy Patients
PRESCRIPTION MEDICATIONS

Smoking Cessation Medications

Smoking Cessation Medications are designed to support individuals who are working to quit tobacco use by reducing cravings and withdrawal symptoms. These therapies may include prescription options that act on nicotine receptors or help stabilize mood during the quitting process. Treatment plans are individualized and often combined with behavioral support to improve long-term success rates. Here you can learn more about each medication in detail.

 

Varenicline (Chantix)

IMPORTANT INFORMATION

Smoking Cessation: A Medical Treatment Goal, Not a Willpower Test

Nicotine dependence is not simply a “bad habit.” It is a biologically reinforced condition involving dopamine reward pathways, withdrawal physiology, stress response, and behavioral cues that become deeply conditioned over time.

Most people who smoke already understand the health risks. The harder part is overcoming nicotine’s powerful reinforcement loop especially during stress, sleep deprivation, or social triggers.

Evidence-based smoking cessation care recognizes that:

  • relapse is common
  • quitting often takes multiple attempts
  • medication can reduce cravings and withdrawal
  • structured follow-up improves long-term success
  • a supportive, non-judgmental approach improves adherence

Telemedicine can be a strong model for smoking cessation because it allows regular check-ins, medication monitoring, and ongoing support without barriers of travel or scheduling.

This page provides a Discover-safe educational overview of smoking cessation, including varenicline (Chantix), how it works, and what safe treatment planning looks like.

Why Quitting Smoking Is Clinically Important

Smoking affects nearly every organ system. Clinicians emphasize cessation because it reduces risk for:

  • cardiovascular disease (heart attack, stroke)
  • chronic lung disease (COPD)
  • multiple cancers
  • fertility and pregnancy complications
  • poor wound healing
  • chronic inflammation and immune dysfunction

Importantly, many health improvements begin quickly after cessation, and long-term risk continues to decline over time.

Understanding Nicotine Withdrawal

Nicotine withdrawal is a predictable physiologic process. Common symptoms include:

  • irritability
  • anxiety
  • restlessness
  • difficulty concentrating
  • sleep disruption
  • increased appetite
  • cravings triggered by routine cues

These symptoms are not a sign of failure they are a sign that the brain is adjusting.

A well-designed quit plan anticipates withdrawal and provides tools to reduce it.

Evidence-Based Smoking Cessation: What Actually Works

Smoking cessation outcomes improve when patients use a combination of:

1) Medication support

Medications reduce cravings and withdrawal severity.

2) Behavioral planning

Patients learn to identify triggers and replace automatic routines.

3) Follow-up and relapse prevention

Regular check-ins help patients stay on track and recover quickly from slips.

This combination is more effective than “cold turkey” quitting for many patients.

Telemedicine and Smoking Cessation: Why It Fits

Telemedicine is often well suited to smoking cessation because:

  • treatment is primarily outpatient
  • medication decisions are history-driven
  • follow-up is essential and can be efficient
  • patients benefit from frequent accountability
  • privacy improves engagement

Telemedicine also supports patients who want discreet care and do not want to discuss smoking cessation in a workplace or community setting.

How Smoking Cessation Telemedicine Works at eSupport Health

At eSupport Health, smoking cessation care is structured around safety, appropriateness, and long-term support.

Step 1 — Structured Intake and Smoking History

Patients provide:

  • cigarettes per day and duration of smoking
  • prior quit attempts and what worked
  • withdrawal symptoms and craving patterns
  • triggers (stress, alcohol, mornings, social settings)
  • current medications and psychiatric history
  • sleep patterns and anxiety/depression screening
  • cardiovascular history and overall health profile

Step 2 — Clinical Review and Safety Screening

A licensed clinician evaluates:

  • appropriateness of varenicline therapy
  • medication interaction risks
  • mental health history and monitoring needs
  • contraindications or special considerations
  • whether additional support is recommended

Step 3 — Quit Plan and Medication Strategy

When clinically appropriate, a clinician may recommend:

  • varenicline therapy
  • a target quit date or structured reduction plan
  • behavioral strategies for cravings and triggers
  • follow-up schedule to support adherence

Step 4 — Follow-Up and Relapse Prevention

Follow-up supports:

  • monitoring side effects
  • reinforcing coping strategies
  • adjusting the plan if cravings persist
  • preventing relapse after early success

Medication in This Category

Your Smoking Cessation category includes:

  • Varenicline (Chantix / Champix)

Below is an educational overview of this medication and its role in treatment.

Varenicline (Chantix): What It Is and How It Works

Varenicline is a prescription medication used to help people stop smoking. It works by partially stimulating nicotine receptors in the brain while also blocking nicotine from cigarettes.

This dual effect can:

  • reduce cravings
  • reduce withdrawal symptoms
  • reduce the “reward” experienced from smoking

In clinical practice, varenicline is considered one of the most effective prescription options for smoking cessation in appropriate patients.

What Patients Should Expect with Varenicline

It works best with a plan

Medication alone is rarely enough. Varenicline works best when paired with:

  • a clear quit strategy
  • trigger management
  • follow-up support

Quitting is often gradual

Some patients stop abruptly on a target date. Others reduce smoking first and stop after cravings decrease. Clinicians tailor the approach to the patient.

Side Effects and Monitoring

Varenicline can cause side effects. Commonly reported effects include:

  • nausea
  • vivid dreams
  • sleep disruption
  • headache
  • mild GI discomfort

These effects are often manageable, but they should be discussed with a clinician.

Mental health monitoring

Smoking cessation itself can affect mood and anxiety, and patients with a history of depression or anxiety benefit from structured monitoring.

A clinician-led plan includes:

  • screening for mood symptoms
  • follow-up during the early quit phase
  • escalation guidance if symptoms worsen

Smoking Cessation and Weight Gain

Some people gain weight after quitting due to:

  • increased appetite
  • changes in taste and food reward
  • replacing smoking with snacking
  • temporary metabolic changes

Clinicians often counsel that:

  • weight changes can be managed
  • the health benefit of quitting is far greater than modest weight gain
  • structured meal planning and activity can reduce risk

This is an area where metabolic care overlaps with smoking cessation.

Relapse Is Common — and It’s Treatable

Many people experience slips or relapse during smoking cessation. Clinically, relapse is not viewed as failure. It is viewed as:

  • a predictable risk
  • a learning opportunity
  • a point where the plan can be strengthened

A good follow-up model helps patients:

  • identify what triggered relapse
  • adjust coping strategies
  • restart treatment quickly

Privacy and Confidentiality in Smoking Cessation Care

Some patients avoid smoking cessation care because they fear judgment. A privacy-first telemedicine model includes:

  • secure communications
  • HIPAA-aligned data handling
  • confidential records and documentation
  • a professional, non-judgmental care approach

This increases engagement and long-term success.

Frequently Asked Questions (FAQ)

What is nicotine dependence? +
Nicotine dependence is a biologically reinforced condition involving reward pathways and withdrawal physiology, not simply a habit.
Can telemedicine help me quit smoking? +
Yes. Telemedicine can support structured evaluation, medication planning, and follow-up monitoring for smoking cessation.
What is varenicline used for? +
Varenicline (Chantix) is a prescription medication used to reduce cravings and withdrawal symptoms to help people quit smoking.
How does varenicline work? +
It partially stimulates nicotine receptors while blocking nicotine from cigarettes, reducing cravings and the rewarding effect of smoking.
How long does varenicline take to work? +
Many patients notice reduced cravings over the first weeks, especially when combined with a quit plan.
What are common side effects of varenicline? +
Common side effects include nausea, vivid dreams, sleep changes, headache, and mild GI discomfort.
Does varenicline affect mood? +
Smoking cessation can affect mood, and patients with mental health history benefit from monitoring. Any worsening mood should be discussed with a clinician.
Can I smoke while taking varenicline? +
Some patients reduce smoking while starting varenicline and then stop on a target date. Clinicians guide the approach.
Will I gain weight if I quit smoking? +
Some people gain weight temporarily. Planning meals and activity can help, and the health benefits of quitting remain substantial.
What if I relapse after quitting? +
Relapse is common. A clinician can help adjust the plan and support a successful restart.
Is quitting smoking safe for everyone? +
Quitting is beneficial for nearly everyone, but patients with complex medical or psychiatric history benefit from structured clinician support.
Is smoking cessation care private? +
Yes. Telemedicine can be private when delivered through secure systems with HIPAA-aligned safeguards.
Get Started Today

Connecting People who Understand MS

Joe Duncan

Chief Executive Officer (CEO)

Joe is the cofounder of eSupport Health and has served as its CEO since the company was formed in November 2019. He is a seasoned executive with over 20 years of experience in founding, building, and leading effective organizations, and whose counsel is sought out across a variety of businesses.

Since 2012, Joe has served as an advisor to the CEO of protocols.io, the leading digital repository for academic research. He led protocols.io’s initial seed round and continues to be actively involved as a trusted advisor to the company.

From 2015 to 2017, Joe served as General Manager at Lionbridge Technologies, where he established the Legal Division, following Lionsbridge’s acquisition of Joe’s company, Geotext Translations, Inc.

In 1997, Joe founded and served as CEO of Geotext, a multimillion-dollar business providing premium language services to global 100 law firms and major corporations. Geotext became the go-to translation company for many of the world’s most critical cross-border legal matters. At its peak, Geotext had over 120 full-time employees and 3,500+ contractors around the world. In 2015, Geotext was acquired by Lionbridge.

Joe holds a B.A. in English Literature, with a Minor in Political Science, from the University of Southern California and an M.F.A. from Columbia University. Joe enjoys reading, running, and hiking in the Adirondacks with his family. Recently Joe learned to surf which involves more wiping out than catching waves, but he enjoys the challenge.